181 related articles for article (PubMed ID: 34537554)
1. Investigation of structural analogs of hydroxychloroquine for SARS-CoV-2 main protease (Mpro): A computational drug discovery study.
Reyaz S; Tasneem A; Rai GP; Bairagya HR
J Mol Graph Model; 2021 Dec; 109():108021. PubMed ID: 34537554
[TBL] [Abstract][Full Text] [Related]
2. One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding.
Kumar P; Bhardwaj T; Kumar A; Garg N; Giri R
J Biomol Struct Dyn; 2022; 40(21):10763-10770. PubMed ID: 34320905
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 envelope protein attain K
Agrahari AK; Srivastava M; Singh M; Asthana S
J Biomol Struct Dyn; 2023; 41(24):15305-15319. PubMed ID: 36907648
[TBL] [Abstract][Full Text] [Related]
4. Structural insight to hydroxychloroquine-3C-like proteinase complexation from SARS-CoV-2: inhibitor modelling study through molecular docking and MD-simulation study.
Mukherjee S; Dasgupta S; Adhikary T; Adhikari U; Panja SS
J Biomol Struct Dyn; 2021 Nov; 39(18):7322-7334. PubMed ID: 32772895
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613
[TBL] [Abstract][Full Text] [Related]
6. Structural and thermodynamic properties of conserved water molecules in Mpro native: A combined approach by MD simulation and Grid Inhomogeneous Solvation Theory.
Bairagya HR; Tasneem A; Sarmadhikari D
Proteins; 2024 Jun; 92(6):735-749. PubMed ID: 38213131
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery.
Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK
Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429
[TBL] [Abstract][Full Text] [Related]
8. Depicting the inhibitory potential of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085
[TBL] [Abstract][Full Text] [Related]
9. Understanding the binding mechanism for potential inhibition of SARS-CoV-2 Mpro and exploring the modes of ACE2 inhibition by hydroxychloroquine.
Choudhury M; Dhanabalan AK; Goswami N
J Cell Biochem; 2022 Feb; 123(2):347-358. PubMed ID: 34741481
[TBL] [Abstract][Full Text] [Related]
10. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
11. Computational study on the affinity of potential drugs to SARS-CoV-2 main protease.
Martín V; Sanz-Novo M; León I; Redondo P; Largo A; Barrientos C
J Phys Condens Matter; 2022 May; 34(29):. PubMed ID: 35504274
[TBL] [Abstract][Full Text] [Related]
12. Systematic identification of chemical components in Fufang Shuanghua oral liquid and screening of potential active components against SARS-CoV-2 protease.
Jiang H; Chen J; Li X; Zhong YT; Kang LP; Wang G; Yu M; Fu LF; Wang P; Xu HY
J Pharm Biomed Anal; 2023 Jan; 223():115118. PubMed ID: 36332330
[TBL] [Abstract][Full Text] [Related]
13. Large scale peptide screening against main protease of SARS CoV-2.
Uddin MJ; Akhter H; Chowdhury U; Mawah J; Karim ST; Jomel M; Islam MS; Islam MR; Onin LAB; Ali MA; Efaz FM; Halim MA
J Comput Chem; 2023 Mar; 44(8):887-901. PubMed ID: 36478400
[TBL] [Abstract][Full Text] [Related]
14. Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.
Patel D; Athar M; Jha PC
J Biomol Struct Dyn; 2022 Apr; 40(7):3071-3081. PubMed ID: 33200683
[TBL] [Abstract][Full Text] [Related]
15. Structural and Dynamical Impact of Water Molecules at Substrate- or Product-Binding Sites in Human GMPR Enzyme: A Study by Molecular Dynamics Simulations.
Bairagya HR; Tasneem A; Rai GP; Reyaz S
J Phys Chem B; 2021 Feb; 125(5):1351-1362. PubMed ID: 33369428
[TBL] [Abstract][Full Text] [Related]
16. Identification of polyphenols from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Biomol Struct Dyn; 2021 Oct; 39(17):6747-6760. PubMed ID: 32762411
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
Rai H; Barik A; Singh YP; Suresh A; Singh L; Singh G; Nayak UY; Dubey VK; Modi G
Mol Divers; 2021 Aug; 25(3):1905-1927. PubMed ID: 33582935
[TBL] [Abstract][Full Text] [Related]
18. Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2.
Paul AS; Islam R; Parves MR; Mamun AA; Shahriar I; Hossain MI; Hossain MN; Ali MA; Halim MA
J Biomol Struct Dyn; 2022 Mar; 40(4):1639-1658. PubMed ID: 33047658
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening, molecular dynamics and structure-activity relationship studies to identify potent approved drugs for Covid-19 treatment.
Rahman MM; Saha T; Islam KJ; Suman RH; Biswas S; Rahat EU; Hossen MR; Islam R; Hossain MN; Mamun AA; Khan M; Ali MA; Halim MA
J Biomol Struct Dyn; 2021 Oct; 39(16):6231-6241. PubMed ID: 32692306
[TBL] [Abstract][Full Text] [Related]
20. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
